T
Ting Gong
Researcher at Tianjin Medical University
Publications - 6
Citations - 4190
Ting Gong is an academic researcher from Tianjin Medical University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 1, co-authored 1 publications receiving 3836 citations.
Papers
More filters
Journal ArticleDOI
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen,Yi Ba,Lijia Ma,Lijia Ma,Xing Cai,Yuan Yin,Kehui Wang,Jigang Guo,Yujing Zhang,Jiangning Chen,Xing Guo,Qibin Li,Qibin Li,Xiaoying Li,Wenjing Wang,Yan Zhang,Jin Wang,Xueyuan Jiang,Yang Xiang,Chen Xu,Pingping Zheng,Juanbin Zhang,Ruiqiang Li,Hongjie Zhang,Xiaobin Shang,Ting Gong,Guang Ning,Jun Wang,Jun Wang,Ke Zen,Junfeng Zhang,Chen-Yu Zhang +31 more
TL;DR: It is demonstrated that miRNAs are present in the serum and plasma of humans and other animals such as mice, rats, bovine fetuses, calves, and horses, and can serve as potential biomarkers for the detection of various cancers and other diseases.
Journal ArticleDOI
Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis
TL;DR: DNA damage repair plays a role in the tumorigenesis and progression of lung squamous cell carcinoma, but the predictive value of DDR in LUSC has not been fully elucidated.
Journal ArticleDOI
Correction to: Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution.
Journal ArticleDOI
Clinical analysis of 78 pulmonary sarcomatoid carcinomas with surgical treatment
TL;DR: Airway dissemination, pleural retraction, metastatic mediastinal lymph node (LN) number, and pathological tumor-node-metastasis (pTNM) stage were risk factors for short OS and neither adjuvant chemotherapy nor adjUvant radiotherapy provided a survival advantage.
Journal ArticleDOI
Retrospective study of EGFR‐mutant lung adenocarcinoma with bone metastatic clinical features
TL;DR: For the patients, treated with EGFR-TKIs ≥6 months, EGFR exon 19 del, osteogenic bone metastasis, bisphosphonate application times ≥6, smoking <400/day and the number of BM <3 were predictors of better OS (p < 05).